[EN] QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR INHIBITORS [FR] DÉRIVÉS DE QUINOLONE À UTILISER EN TANT QU'INHIBITEURS DE FACTEUR DE CROISSANCE DES FIBROBLASTES
[EN] QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR INHIBITORS [FR] DÉRIVÉS DE QUINOLONE À UTILISER EN TANT QU'INHIBITEURS DE FACTEUR DE CROISSANCE DES FIBROBLASTES
A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided.
A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.
A compound which may be used for the prevention or treatment of respiratory diseases in which STAT 6 is concerned, particularly asthma, chronic obstructive pulmonary disease and the like is provided.
A pyrimidine derivative or a salt thereof, which has an arylamino or arylethylamino group which may be substituted with a specified substituent, at the 2-position, amino group substituted with benzyl group or the like, at the 4-position, and carbamoyl group which may be substituted, at the 5-position, is provided.
QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR INHIBITORS
申请人:Principia Biopharma, Inc.
公开号:US20160130268A1
公开(公告)日:2016-05-12
Compounds that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for preparing such compounds.